APA aipamena

Duployez, N., Grzych, G., Ducourneau, B., Fuentes, M. A., Grardel, N., Boyer, T., . . . Preudhomme, C. (2016). NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors. Haematologica.

Chicago Style aipamena

Duployez, Nicolas, et al. "NUP214-ABL1 Fusion Defines a Rare Subtype of B-cell Precursor Acute Lymphoblastic Leukemia That Could Benefit From Tyrosine Kinase Inhibitors." Haematologica 2016.

MLA aipamena

Duployez, Nicolas, et al. "NUP214-ABL1 Fusion Defines a Rare Subtype of B-cell Precursor Acute Lymphoblastic Leukemia That Could Benefit From Tyrosine Kinase Inhibitors." Haematologica 2016.